FDA Approval Activities for this Drug
BARACLUDE (entecavir) Film-Coated Tablets, Bristol-Myers Squibb, Approval | BARACLUDE (entecavir) Oral Solution, Bristol-Myers Squibb, Approval | BARACLUDE (entecavir) Film-Coated Tablets, Bristol-Myers Squibb, Efficacy Supp. w/Clinical Data | BARACLUDE (entecavir) Oral Solution, Bristol-Myers Squibb, Efficacy Supp. w/Clinical Data | BARACLUDE (entecavir) Tablets, Bristol-Myers Squibb, New Dosage Regimen | BARACLUDE (entecavir) Oral Solution, Bristol-Myers Squibb, New Dosage Regimen | BARACLUDE (entecavir) Tablets, Bristol-Myers Squibb, New Dosage Regimen | BARACLUDE (entecavir) Oral Solution, Bristol-Myers Squibb, New Dosage Regimen | BARACLUDE (entecavir) Tablets, Bristol-Myers Squibb, Labeling Revision | BARACLUDE (entecavir) Oral Solution, Bristol-Myers Squibb, Labeling Revision | BARACLUDE (entecavir) Tablets, Bristol-Myers Squibb Company, Labeling Revision | BARACLUDE (entecavir) Oral Solution, Bristol-Myers Squibb Company, Labeling Revision | Baraclude (entecavir) Oral Solution, Bristol-Myers Squibb Co., Efficacy Supplement with Clinical Data to Support | Baraclude (entecavir) Tablets, Bristol-Myers Squibb Co., Efficacy Supplement with Clinical Data to Support